U.S. markets close in 5 hours 4 minutes
  • S&P 500

    +29.15 (+0.89%)
  • Dow 30

    +118.64 (+0.45%)
  • Nasdaq

    +122.50 (+1.11%)
  • Russell 2000

    +6.72 (+0.44%)
  • Crude Oil

    -1.42 (-3.80%)
  • Gold

    -3.40 (-0.18%)
  • Silver

    +0.22 (+0.95%)

    -0.0070 (-0.60%)
  • 10-Yr Bond

    +0.0200 (+2.56%)

    -0.0067 (-0.52%)

    +0.1500 (+0.14%)

    +250.98 (+1.91%)
  • CMC Crypto 200

    +22.04 (+9.08%)
  • FTSE 100

    +16.42 (+0.29%)
  • Nikkei 225

    -86.57 (-0.37%)

What Does BioLife Solutions, Inc.'s (NASDAQ:BLFS) Share Price Indicate?

Simply Wall St
·3 mins read

BioLife Solutions, Inc. (NASDAQ:BLFS), which is in the medical equipment business, and is based in United States, saw a double-digit share price rise of over 10% in the past couple of months on the NASDAQCM. As a stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. But what if there is still an opportunity to buy? Let’s take a look at BioLife Solutions’s outlook and value based on the most recent financial data to see if the opportunity still exists.

Check out our latest analysis for BioLife Solutions

What's the opportunity in BioLife Solutions?

Good news, investors! BioLife Solutions is still a bargain right now. I’ve used the price-to-earnings ratio in this instance because there’s not enough visibility to forecast its cash flows. The stock’s ratio of 25.34x is currently well-below the industry average of 48.27x, meaning that it is trading at a cheaper price relative to its peers. What’s more interesting is that, BioLife Solutions’s share price is quite volatile, which gives us more chances to buy since the share price could sink lower (or rise higher) in the future. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.

Can we expect growth from BioLife Solutions?

NasdaqCM:BLFS Past and Future Earnings, February 17th 2020
NasdaqCM:BLFS Past and Future Earnings, February 17th 2020

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. BioLife Solutions’s earnings over the next few years are expected to double, indicating a very optimistic future ahead. This should lead to stronger cash flows, feeding into a higher share value.

What this means for you:

Are you a shareholder? Since BLFS is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current undervaluation.

Are you a potential investor? If you’ve been keeping an eye on BLFS for a while, now might be the time to make a leap. Its prosperous future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy BLFS. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed buy.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on BioLife Solutions. You can find everything you need to know about BioLife Solutions in the latest infographic research report. If you are no longer interested in BioLife Solutions, you can use our free platform to see my list of over 50 other stocks with a high growth potential.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.